Does Washington Medicaid cover Ozempic or Wegovy or Rybelsus for weight loss?

Other indications only. Approvable at 18 or over with established cardiovascular disease at a BMI of 27, or for moderate to severe MASH. No weight-management route in the policy

Does Washington Medicaid cover Mounjaro or Zepbound for weight loss?

Other indications only. Approvable at 18 or over for obstructive sleep apnea, defined as an AHI or RDI of 15 or more

Medicaid coverage

Washington: what Medicaid covers

Washington writes one clinical policy per medicine, and each names the conditions it may be approved for. Wegovy lists cardiovascular events and MASH. Zepbound lists obstructive sleep apnea. Neither policy contains a chronic weight management route.

Checked against the primary source August 25, 2026

What Medicaid in Washington covers, and the criteria that apply.
Drug	Position	Criteria
Semaglutide	Other indications only	Approvable at 18 or over with established cardiovascular disease at a BMI of 27, or for moderate to severe MASH. No weight-management route in the policy
Tirzepatide	Other indications only	Approvable at 18 or over for obstructive sleep apnea, defined as an AHI or RDI of 15 or more
Liraglutide	not checked	Washington publishes a policy per molecule. There is no published Saxenda policy alongside the Wegovy and Zepbound ones

Semaglutide Other indications only

Approvable at 18 or over with established cardiovascular disease at a BMI of 27, or for moderate to severe MASH. No weight-management route in the policy
Tirzepatide Other indications only

Approvable at 18 or over for obstructive sleep apnea, defined as an AHI or RDI of 15 or more
Liraglutide not checked

Washington publishes a policy per molecule. There is no published Saxenda policy alongside the Wegovy and Zepbound ones

If the answer is no. Around 45% of initial prior authorizations for these drugs are refused, and 35 to 45% of first-level appeals are overturned. A refusal is not the end of the process, and the cash-pay routes are priced on this site alongside it.

Sources

Every claim above is checked against the primary text, and the date is the day we last opened it.

1
Medical policy 61.25.20.AA: Anorexiants/Anti-Obesity GLP-1 Receptor Agonists, Wegovy
Washington State Health Care Authority, Apple Health Primary text read and checked Checked August 25, 2026
2
Medical policy 61.25.25.AA: Anorexiants/Anti-Obesity GLP-1 Receptor Agonists, Zepbound
Washington State Health Care Authority, Apple Health Primary text read and checked Checked August 25, 2026